97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
Method of reducing formation of etanercept aggregates or fragments
#1202Stable aqueous etanercept composition
#1203Method of Reducing Formation of Etanercept Aggregates or Fragments
#1204Polypeptide and method of producing IMP using the same
#1205Methods of promoting CNS neuronal repair by inhibiting LRP-1
#1206Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1207Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1208Tris- or neopentyl glycol-based amphiphiles and uses thereof
#1209TAG-72-binding chimeric antigen receptors
#1210GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS
#1211Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
#1212TARGETED IMMUNOSUPPRESSION FOR OPTOGENETIC INTERVENTION
#1213Use of toll-like receptor agonist for treating cancer
#1214PEPTIDE
#1215Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment
#1216Transferrin receptor transgenic models
#1217IL-6 antibodies and fusion constructs and conjugates thereof
#1218Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#1219Peptides and combination of peptides for use in immunotherapy against various cancers
#1220Modified natural killer cells for the treatment of cancer
#1221GPCR (GPR113) INVOLVED IN FAT, FATTY ACID AND/OR LIPID-ASSOCIATED TASTE AND USE IN ASSAYS FOR IDENTIFYING TASTE MODULATORY
#1222Modified membrane spanning proteins and methods for the preparation and use thereof
#1223Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1224Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1225METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#1226Polypeptide and use thereof
#1227Peptides and combination of peptides for use in immunotherapy against various cancers
#1228Compositions and methods for TCR reprogramming using fusion proteins
#1229Modulation of novel immune checkpoint targets
#1230Enhancement of CD47 blockade therapy by proteasome inhibitors
#1231Multimeric coding nucleic acid and uses thereof
#1232Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof
#1233Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions
#1234POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR
#1235Methods and compositions for treating cancer
#1236Modified cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides with increased stability and uses thereof
#1237METHODS FOR REDUCING CD36 EXPRESSION
#1238Cell-associated secretion-enhancing fusion proteins
#1239Mesitylene-cored amphiphiles and uses thereof
#1240MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#1241Methods and compositions relating to covalently circularized nanodiscs
#1242Slit2D2-chimeric antigen receptor and application thereof
#1243Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
#1244Inducible caspases and methods for use
#1245Odorant receptor co-receptor
#1246Materials and methods for treatment of pain related disorders
#1247Toll-like receptor 2 agonists and vaccines and uses thereof
#1248Method for identifying modulators of notch signaling
#1249Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
#1250Nucleic acid encoding angiopoietin-2 specific Tie2 receptor
#1251ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF
#1252Mutant light-inducible ion channel of chrimson
#1253MUTANT LIGHT-INDUCIBLE ION CHANNEL OF CHANNELRHODOPSIN
#1254Transduction
#1255Etanercept formulations stabilized with amino acids
#1256Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance
#1257Modified cell expansion and uses thereof
#1258Protein production in microorganisms of the phylum labyrinthulomycota
#1259Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#1260Proteolytically cleavable chimeric polypeptides and methods of use thereof
#1261Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
#1262Chimeric antigen receptors targeting CD-19
#1263GPR156 variants and uses thereof
#1264ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
#1265TauT (taurine transporter) peptide cancer vaccine
#1266Adeno-associated virus vector delivery of B-sarcoglycan and microrna-29 and the treatment of muscular dystrophy
#1267Synthetic compound
#1268Signaling and antigen-presenting bifunctional receptors (SABR)
#1269Methods and compositions for screening and treating developmental disorders
#1270T cell compositions
#1271KLRG1 DEPLETION THERAPY
#1272METHODS OF IDENTIFYING EPITOPES
#1273ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE
#1274Agent for restoring visual function or agent for preventing deterioration in visual function
#1275Methods and compositions for treating diseases and disorders of the nervous system
#1276Method of manufacturing membrane protein and utilization thereof
#1277SOLID PHASE PEPTIDE SYNTHESIS
#1278Methods for increasing palatability of pet foodstuff
#1279COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION
#1280Etanercept formulations stabilized with xylitol
#1281IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND DERIVATIVES THEREOF
#1282Human Notch1 based fusion proteins as decoy inhibitors of jagged-notch signaling and DLL-notch signaling
#1283Compounds for the treatment of neuromuscular disorders
#1284Fusion protein comprising apelin and an anti-APLNR antibody
#1285DSG2-derived peptides
#1286Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1287Chloride salt of TAT-NR2B9c
#1288Methods for identifying modulators of GPR92
#1289PHEROMONAL RECEPTOR OF SPODOPTERA LITTORALIS AND IDENTIFICATION OF NATURAL LIGAND OF SAID RECEPTOR AND USES THEREOF
#1290BTNL3 proteins, nucleic acids and antibodies and uses thereof
#1291USE OF HIGH AFFINITY MONOCLONAL ANTIBODY PRODUCT BINDERS TO INCREASE THE DURATION OF ACTION OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS IN A BIOLOGIC TISSUE
#1292Compositions and methods for neurological diseases
#1293CLAUDIN-6 PEPTIDES
#1294Biomarkers for non-hodgkin lymphomas and uses thereof
#1295Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
#1296Materials and methods for treatment of pain related disorders
#1297Composition for delivery of genetic material
#1298Anti-BCMA chimeric antigen receptor
#1299Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof
#1300Lipopeptides for use in treating liver diseases and cardiovascular diseases
#1301Anti-CD7 chimeric antigen receptor and method of use thereof
#1302Formulation containing TLR agonist and methods of use
#1303Peptides of syndecan-1 for inhibiting angiogenesis
#1304Methods and compositions for the treatment of radiation-related disorders
#1305Stable nanolipoprotein particles and related compositions methods and systems
#1306Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
#1307Systems and methods for targeting cancer cells
#1308SUPPRESSION OF CANCER
#1309Engineered PD-1 variants
#1310Method for producing TLR5 agonist protein
#1311DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS
#1312Cancer gene therapy targeting CD47
#1313PAR3 mimetic peptides and uses thereof
#1314Artificial synapse inducer and method of making the same
#1315NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES
#1316MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES
#1317PAR2 mimetic peptides and uses thereof
#1318TUMOR ANTIGEN PEPTIDE
#1319PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS
#1320GJA1 isoforms protect against metabolic stress
#1321Biosensors for chloride ions
#1322Stable proteins
#1323ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH
#1324Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
#1325Compositions and their use for controlling the nervous system in vivo
#1326Polypeptide compositions comprising spacers
#1327Compositions and methods targeting HCN channels for breathing therapeutics
#1328Calcium sensing receptors, ligands, compositions, and methods of use
#1329ALK4:ActRIIB heteromultimers and uses thereof
#1330METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS
#1331Methods and systems for producing nanolipoprotein particles
#1332Disease-associated antigens and methods of use thereof
#1333Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1334Stapled peptides and uses thereof
#1335Cyclic peptide conjugates and methods of use
#1336Immunity-inducing agent
#1337Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers
#1338Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers
#1339In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants
#1340TIR taste receptors and genes encoding same
#1341Using DREADD for neuronal modulation in treating neuronal diseases
#1342AAV-MEDIATED SUBCELLULAR TARGETING OF HETEROLOGOUS RHODOPSINS IN RETINAL GANGLION CELLS
#1343Compositions and methods related to multimodal therapeutic cancer indications
#1344Step-function channelrhodopsins for optical control of cells
#1345CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION
#1346Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1347Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
#1348Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
#1349Immunity-inducing agent
#1350Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma
#1351PEPTIDE INHIBITORS OF SODIUM CHANNELS
#1352Peptides and combination of peptides for use in immunotherapy against NHL and other cancers
#1353Configuring a smart home controller
#1354Engineered antigen presenting cells and uses thereof
#1355Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
#1356Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#1357Antigen-specific T cell receptors and T cell epitopes
#1358EXPRESSION CONSTRUCTS AND METHODS FOR SELECTING HOST CELLS EXPRESSING POLYPEPTIDES
#1359Methods of propagating rhinovirus C in previously unsusceptible cell lines
#1360Binding members to PD-L1
#1361Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy
#1362Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#1363BIOMARKER FOR USE IN TREATING ANEMIA
#1364Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#1365LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
#1366OMA1 activity assay
#1367MODIFIED CELLS FOR IMMUNOTHERAPY
#1368Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
#1369Recombinant chimeric protein for selectins targeting
#1370Compositions comprising TREM2 and methods of use thereof
#1371Compositions and Methods for Treating Neuropathic Pain
#1372PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#1373Polypeptide selectively binding to immunoglobulin G of mouse or rabbit and use thereof
#1374Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies
#1375Cell derived extracellular vesicles for the treatment of diseases
#1376Anti-PD-1 antibody and use thereof
#1377Method for producing erythrocyte proteins
#1378EPHA2 t-cell epitope agonists and uses therefore
#1379Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#1380Modulators of zinc activated cation channel
#1381NUCLEIC ACIDS ENCODING A G-PROTEIN COUPLED RECEPTOR INVOLVED IN SENSORY TRANSDUCTION
#1382Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1383Immunogenic Compositions
#1384EGF(A) analogues with fatty acid substituents
#1385Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
#1386Peptides and combination of peptides for use in immunotherapy against various cancers
#1387MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
#1388Chimeric protein
#1389Human ARCAP transgenic mouse
#1390Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
#1391Synthetic protein for modulating gene expression
#1392Composition comprised of antigen linked to a TNF superfamily ligand
#1393Conditionally active chimeric antigen receptors for modified t-cells
#1394Targeted expression of chloride channels and methods of use thereof
#1395Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses thereof
#1396Genetically encoded red fluorescent voltage sensors enabling millivolt-resolution and high-speed neural voltage imaging
#1397Gene therapy for treating familial hypercholesterolemia
#1398PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES
#1399Methods and compositions for the inhibition of TRPV4
#1400Therapeutic agents
#1401Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#1402Calcium indicator polypeptides and methods of use thereof
#1403HIGH AFFINITY NY-ESO T CELL RECEPTORS
#1404MRNA combination therapy for the treatment of cancer
#1405Vectors for expression of prostate-associated antigens
#1406High affinity T cell receptors and uses thereof
#1407A renal cell line with stable transporter expression
#1408Methods and antibodies for modulation of immunoresponse
#1409Methods and compositions for promoting thermogenic potential
#1410Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#1411MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
#1412Peptides and combination of peptides for use in immunotherapy against various cancers
#1413Peptides and combination of peptides for use in immunotherapy against various cancers
#1414Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
#1415Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
#1416Compounds for treating neurodegenerative proteinopathies
#1417Modified chimeric receptors and related compositions and methods
#1418Binding-triggered transcriptional switches and methods of use thereof
#1419Gene therapy for the treatment of a disease of retinal cone cells
#1420Ferritin nanoparticle compositions and methods to modulate cell activity
#1421Cancer antigen targets and uses thereof
#1422Mutations in rhodopsin gene in zebrafish and uses thereof
#1423Synthetic notch protein for modulating gene expression
#1424PEPTIDES
#1425Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use
#1426Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1427Siglec-10 antibodies
#1428Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers
#1429Use of toll-like receptor agonist for treating cancer
#1430Methods of treating muscular dystrophy
#1431ROR1 antibody compositions and related methods
#1432Conditionally active chimeric antigen receptors for modified T-cells
#1433Methods to spatially profile protease activity in tissue and sections
#1434Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors
#1435Transgenic macrophages, chimeric antigen receptors, and associated methods
#1436OPTICALLY-CONTROLLED CNS DYSFUNCTION
#1437Method for modulating insulin-independent glucose transport using teneurin C-terminal associated peptide (TCAP)
#1438Light-activated cation channel and uses thereof
#1439toxin receptors and uses thereof
#1440CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation
#1441TARGETED DELIVERY OF THERAPEUTIC PROTEINS BIOENCAPSULATED IN PLANT CELLS TO CELL TYPES OF INTEREST FOR THE TREATMENT OF DISEASE
#1442Methods and compositions for modulating AAV infection
#1443Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#1444FUNCTIONAL REGULATORY ANTIBODY HAVING ACTIONS OF PROMOTING PROLIFERATION, SURVIVAL, AND CELL ACTIVATION OF DERMAL PAPILLA CELLS AS HAIR GROWTH REGULATING CENTER CELLS AND USE THEREOF
#1445PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY
#1446Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#1447Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins
#1448PSMA-specific binding proteins
#1449Host cells and systems for membrane protein expression
#1450Fc FUSION HIGH AFFINITY IgE RECEPTOR ALPHA-CHAIN
#1451WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#1452Modified Polynucleotides for the production of biologics and proteins associated with human disease
#1453Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
#1454Nanoparticle formulations for delivery of nucleic acid complexes
#1455T cell receptors and immune therapy using the same
#1456Chimeric antigen receptors and methods of use
#1457Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum
#1458Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty Liver
#1459Biosensors for cellular osmolarity
#1460POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#1461Cell lines for screening odorant and aroma receptors
#1462Anti-podocalyxin antibodies and methods of using the same
#1463Anti-Tie2 antibodies and uses thereof
#1464ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES
#1465High-affinity and soluble PDL-1 molecule
#1466Method for preparing genetically-modified T cells which express chimeric antigen receptor
#1467AGENTS FOR REDUCING THE ACTIVITY OF GDF15
#1468Claudin-18.2-specific immunoreceptors and T cell epitopes
#1469ENGINEERED LISTERIA AND METHODS OF USE THEREOF
#1470In vitro production of red blood cells with sortaggable proteins
#1471METHODS AND DEVICES FOR DETECTING PROTEIN IN SALIVA SAMPLES
#1472Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#1473Chimeric proteins and methods of regulating gene expression
#1474Activation of taste receptor genes in mammalian cells using CRISPR-Cas-9
#1475Humanized or affinity-matured anti ang-2 antibody and uses thereof
#1476Method of Identifying Transmembrane Protein-interacting Compounds
#1477METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES
#1478Methods of treating cancer with a P2X7 peptide
#1479Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof
#1480Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1481Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)
#1482Core constructs and their uses in configuring pharmaceutical molecules
#1483Use of a cyclic tripeptide for improving cellular energy metabolism
#1484Therapeutical tools and methods for treating blindness by targeting photoreceptors
#1485Tumor marker for the rhabdomyosarcoma
#1486Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#1487Compositions and Methods for the Diagnosis of Retinal Neovascularization
#1488Fusion immunomodulatory proteins and methods for making same
#1489Mesothelin-targeted chimeric antigen receptors and methods of making them
#1490Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
#1491ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE
#1492Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1493Tumor infiltrating lymphocytes for treatment of cancer
#1494MODIFIED CELLS EVOKING REDUCED IMMUNOGENIC RESPONSES
#1495Method of using mouse having a humanized cluster of differentiation 47 gene
#1496Soybean ROD1 gene sequences and uses thereof
#1497Cell support composite and method for producing cell support composite
#1498P2X7 receptor antagonists and agonists
#1499EPHA3 and multi-valent targeting of tumors
#1500Molecular signature of cancer